These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 36242524

  • 1. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine.
    Vora D, Banga AK.
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1539-1548. PubMed ID: 36242524
    [Abstract] [Full Text] [Related]

  • 2. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD, Gutierrez M, Flynn GL, Cleary GW.
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [Abstract] [Full Text] [Related]

  • 3. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
    Ameen D, Michniak-Kohn B.
    Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
    [Abstract] [Full Text] [Related]

  • 4. Hypothesizing the Oleic Acid-Mediated Enhanced and Sustained Transdermal Codelivery of Pregabalin and Diclofenac Adhesive Nanogel: A Proof of Concept.
    Datta D, Noor A, Rathee A, Singh S, Kohli K.
    Curr Mol Med; 2024 Jun; 24(11):1317-1328. PubMed ID: 38847251
    [Abstract] [Full Text] [Related]

  • 5. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
    Soler LI, Boix A, Lauroba J, Colom H, Domenech J.
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
    [Abstract] [Full Text] [Related]

  • 6. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
    Naruse M, Ogawara K, Kimura T, Konishi R, Higaki K.
    Eur J Pharm Sci; 2014 Feb 14; 52():86-94. PubMed ID: 24215737
    [Abstract] [Full Text] [Related]

  • 7. Development and evaluation of transdermal delivery system of tranylcypromine for the treatment of depression.
    Shrestha N, Banga AK.
    Drug Deliv Transl Res; 2023 Apr 14; 13(4):1048-1058. PubMed ID: 36482163
    [Abstract] [Full Text] [Related]

  • 8. Impact of Different Mixing Methods on the Performance of Suspension-Based Transdermal Delivery Systems.
    Bhattaccharjee SA, Kale M, Le N, Banga AK.
    AAPS PharmSciTech; 2021 May 10; 22(4):150. PubMed ID: 33973096
    [Abstract] [Full Text] [Related]

  • 9. Effect of Different Pressure-Sensitive Adhesives on Performance Parameters of Matrix-Type Transdermal Delivery Systems.
    Bozorg BD, Banga AK.
    Pharmaceutics; 2020 Mar 01; 12(3):. PubMed ID: 32121515
    [Abstract] [Full Text] [Related]

  • 10. Drug recrystallization in drug-in-adhesive transdermal delivery system: A case study of deteriorating the mechanical and rheological characteristics of testosterone TDS.
    Mohamed LA, Kamal N, Elfakhri KH, Willett D, Wokovich A, Strasinger C, Cruz CN, Raney SG, Ashraf M, Zidan AS.
    Int J Pharm; 2020 Mar 30; 578():119132. PubMed ID: 32057892
    [Abstract] [Full Text] [Related]

  • 11. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
    Lobo S, Sachdeva S, Goswami T.
    Ther Deliv; 2016 Mar 30; 7(1):33-48. PubMed ID: 26652621
    [Abstract] [Full Text] [Related]

  • 12. Development of drug-in-adhesive transdermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation.
    Hu Y, Wu YY, Xia XJ, Wu Z, Liang WQ, Gao JQ.
    Drug Deliv; 2011 Jan 30; 18(1):84-9. PubMed ID: 20939674
    [Abstract] [Full Text] [Related]

  • 13. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation.
    Aggarwal G, Dhawan S, HariKumar SL.
    Curr Drug Deliv; 2012 Mar 30; 9(2):172-81. PubMed ID: 22023211
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Formulation and evaluation of ubidecarenone transdermal delivery systems.
    Jung SY, Kang EY, Choi YJ, Chun IK, Lee BK, Gwak HS.
    Drug Dev Ind Pharm; 2009 Sep 30; 35(9):1029-34. PubMed ID: 19365779
    [Abstract] [Full Text] [Related]

  • 20. Water-compatible cross-linked pyrrolidone acrylate pressure-sensitive adhesives with persistent adhesion for transdermal delivery: Synergistic effect of hydrogen bonding and electrostatic force.
    Gong K, Sun P, Cai Y, Wang X, Pang Y, Liu C, Guo J, Fang L.
    Acta Biomater; 2024 Apr 15; 179():130-148. PubMed ID: 38460932
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.